Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone.
Leav
B A
BA
Fanburg
B
B
Hadley
S
S
D000280:Administration, Inhalation; D000309:Adrenal Insufficiency / Q000139:chemically induced; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001228:Aspergillosis / Q000139:chemically induced*; D001249:Asthma / Q000188:drug therapy; D000068298:Fluticasone; D006801:Humans; D008172:Lung Diseases, Fungal / Q000139:chemically induced*; D008297:Male
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone